Literature DB >> 16917197

Genetic epidemiology of Alzheimer disease.

Richard Mayeux1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16917197     DOI： 10.1097/00002093-200607001-00008

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN： 0893-0341            Impact factor:   2.703


× No keyword cloud information.
  7 in total

1.  PF-04494700, an oral inhibitor of receptor for advanced glycation end products (RAGE), in Alzheimer disease.

Authors:  Marwan N Sabbagh; Albert Agro; Joanne Bell; Paul S Aisen; Edward Schweizer; Douglas Galasko
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Jul-Sep       Impact factor: 2.703

2.  Exceptional brain aging in a rural population-based cohort.

Authors:  Jeffrey Kaye; Yvonne Michael; James Calvert; Marjorie Leahy; Debbie Crawford; Patricia Kramer
Journal:  J Rural Health       Date:  2009       Impact factor: 4.333

Review 3.  Neurodegenerative diseases: neurotoxins as sufficient etiologic agents?

Authors:  Christopher A Shaw; Günter U Höglinger
Journal:  Neuromolecular Med       Date:  2007-11-06       Impact factor: 3.843

4.  Genetic aspects of behavioral neurotoxicology.

Authors:  Edward D Levin; Michael Aschner; Ulrike Heberlein; Douglas Ruden; Kathleen A Welsh-Bohmer; Selena Bartlett; Karen Berger; Lang Chen; Ammon B Corl; Donnie Eddins; Rachael French; Kathleen M Hayden; Kirsten Helmcke; Helmut V B Hirsch; Elwood Linney; Greg Lnenicka; Grier P Page; Debra Possidente; Bernard Possidente; Annette Kirshner
Journal:  Neurotoxicology       Date:  2009-07-30       Impact factor: 4.294

Review 5.  Latrepirdine, a potential novel treatment for Alzheimer's disease and Huntington's chorea.

Authors:  Marwan N Sabbagh; Holly A Shill
Journal:  Curr Opin Investig Drugs       Date:  2010-01

Review 6.  Reflections on the Future of Pharmaceutical Public-Private Partnerships: From Input to Impact.

Authors:  Remco L A de Vrueh; Daan J A Crommelin
Journal:  Pharm Res       Date:  2017-06-06       Impact factor: 4.200

7.  Clinical Aspects of Foot Health in Individuals with Alzheimer's Disease.

Authors:  Daniel López-López; Marta Grela-Fariña; Marta Elena Losa-Iglesias; César Calvo-Lobo; David Rodríguez-Sanz; Patricia Palomo-López; Ricardo Becerro-de-Bengoa-Vallejo
Journal:  Int J Environ Res Public Health       Date:  2018-02-07       Impact factor: 3.390
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.